These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 19536866)
1. Angiogenesis as a strategic target for prostate cancer therapy. Li Y; Cozzi PJ Med Res Rev; 2010 Jan; 30(1):23-66. PubMed ID: 19536866 [TBL] [Abstract][Full Text] [Related]
2. Novel targets and approaches in advanced prostate cancer. Hadaschik BA; Sowery RD; Gleave ME Curr Opin Urol; 2007 May; 17(3):182-7. PubMed ID: 17414516 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale. Ryan CJ; Lin AM; Small EJ Urol Oncol; 2006; 24(3):250-3. PubMed ID: 16678059 [TBL] [Abstract][Full Text] [Related]
4. Promising tumor-associated antigens for future prostate cancer therapy. Li Y; Cozzi PJ; Russell PJ Med Res Rev; 2010 Jan; 30(1):67-101. PubMed ID: 19536865 [TBL] [Abstract][Full Text] [Related]
5. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis of prostate cancer and antiangiogenic therapy. Uehara H J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383 [TBL] [Abstract][Full Text] [Related]
7. New drugs in prostate cancer. Armstrong AJ; Carducci MA Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms and therapeutic development of angiogenesis inhibitors. Cao Y Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of the tumor vasculature. Tozer GM; Bicknell R Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: status of current treatments and emerging antisense-based therapies. Devi GR Curr Opin Mol Ther; 2002 Apr; 4(2):138-48. PubMed ID: 12044035 [TBL] [Abstract][Full Text] [Related]
12. Antiangiogenesis: a possible treatment option for prostate cancer? Longoria RL; Cox MC; Figg WD Clin Genitourin Cancer; 2005 Dec; 4(3):197-202. PubMed ID: 16425989 [TBL] [Abstract][Full Text] [Related]
13. Targeting uPA/uPAR in prostate cancer. Li Y; Cozzi PJ Cancer Treat Rev; 2007 Oct; 33(6):521-7. PubMed ID: 17658220 [TBL] [Abstract][Full Text] [Related]
14. Management of prostate cancer. Part 3: metastatic disease. Shah J; Khaksar SJ; Sooriakumaran P Expert Rev Anticancer Ther; 2006 May; 6(5):813-21. PubMed ID: 16759171 [TBL] [Abstract][Full Text] [Related]
15. Combined androgen blockade: the gold standard for metastatic prostate cancer. McLeod DG; Crawford ED; DeAntoni EP Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789 [TBL] [Abstract][Full Text] [Related]
16. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
17. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways. Roy V; Perez EA Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
19. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment. Gagne P; Akalu A; Brooks PC Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663 [TBL] [Abstract][Full Text] [Related]